Approval Status of Cancer Cell Therapy at Risk After Halting Phase III Trial
Following an unfavorable interim analysis, Milan-based MolMed has suspended a phase III trial of its…
Following an unfavorable interim analysis, Milan-based MolMed has suspended a phase III trial of its…
Spun out of the University of Milano-Bicocca, the Italian biotech Fem2-Ambiente aids in the fight…
The Swiss-Italian biotech company Philogen has raised a private round of €62M to fund the…
A skin cream developed by the Italian company Cassiopea has reduced male-pattern baldness for up…
The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to…
Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies…
The Italian biotech Cassiopea reports good news for acne sufferers. Its hormonal anti-acne treatment Winlevi…
Today, we’re in Faenza, Italy, visiting GreenBone, a biotech developing wood-derived bone implants for patients…
An EU project is using forestry waste to make 2,3-butanediol, a chemical with a wide…
Many European countries, including the UK, France, Germany, and Switzerland, boast a thriving biotech industry. Others…
EryDel has raised €26.5M to develop a red blood cell drug delivery system to treat a…
Cell and gene therapies have recently made big advances in providing effective treatments for a…